Murphy M, Buzinova V, Johnson C
Biochim Biophys Acta Mol Basis Dis. 2023; 1870(2):166945.
PMID: 37935338
PMC: 10842071.
DOI: 10.1016/j.bbadis.2023.166945.
Aloufi B, Alshammari A, Alshammari N, Alam M
Bioinformation. 2023; 18(7):622-629.
PMID: 37313055
PMC: 10259223.
DOI: 10.6026/97320630018622.
Alraawi Z, Banerjee N, Mohanty S, Kumar T
Int J Mol Sci. 2022; 23(22).
PMID: 36430450
PMC: 9695042.
DOI: 10.3390/ijms232213970.
Hefner M, Baliga V, Amphay K, Ramos D, Hegde V
Front Aging Neurosci. 2021; 13:721858.
PMID: 34497507
PMC: 8419421.
DOI: 10.3389/fnagi.2021.721858.
Rahman M, Akter R, Bhattacharya T, Abdel-Daim M, Alkahtani S, Arafah M
Front Pharmacol. 2021; 11:619024.
PMID: 33456444
PMC: 7804889.
DOI: 10.3389/fphar.2020.619024.
ameliorates scopolamine-induced cognitive dysfunction.
Xu Y, Wang X, Xu T, Li H, Hei S, Luo N
Neural Regen Res. 2019; 14(5):794-804.
PMID: 30688265
PMC: 6375048.
DOI: 10.4103/1673-5374.249227.
Antibody Therapeutics Targeting Aβ and Tau.
Gallardo G, Holtzman D
Cold Spring Harb Perspect Med. 2017; 7(10).
PMID: 28062555
PMC: 5500436.
DOI: 10.1101/cshperspect.a024331.
Resveratrol as a therapeutic agent for Alzheimer's disease.
Ma T, Tan M, Yu J, Tan L
Biomed Res Int. 2014; 2014:350516.
PMID: 25525597
PMC: 4261550.
DOI: 10.1155/2014/350516.
Amyloid β peptides modify the expression of antioxidant repair enzymes and a potassium channel in the septohippocampal system.
Duran-Gonzalez J, Michi E, Elorza B, Perez-Cordova M, Pacheco-Otalora L, Touhami A
Neurobiol Aging. 2013; 34(8):2071-6.
PMID: 23473707
PMC: 4890633.
DOI: 10.1016/j.neurobiolaging.2013.02.005.
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.
Castellano J, Kim J, Stewart F, Jiang H, DeMattos R, Patterson B
Sci Transl Med. 2011; 3(89):89ra57.
PMID: 21715678
PMC: 3192364.
DOI: 10.1126/scitranslmed.3002156.
Alzheimer's disease: the challenge of the second century.
Holtzman D, Morris J, Goate A
Sci Transl Med. 2011; 3(77):77sr1.
PMID: 21471435
PMC: 3130546.
DOI: 10.1126/scitranslmed.3002369.
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.
Lassmann H
J Neural Transm (Vienna). 2011; 118(5):747-52.
PMID: 21373761
DOI: 10.1007/s00702-011-0607-8.
Apolipoprotein E in Alzheimer's disease and other neurological disorders.
Verghese P, Castellano J, Holtzman D
Lancet Neurol. 2011; 10(3):241-52.
PMID: 21349439
PMC: 3132088.
DOI: 10.1016/S1474-4422(10)70325-2.
Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles.
Han S, Chang Y, Jung E, Kim J, Na D, Mook-Jung I
Int J Nanomedicine. 2011; 6:1-12.
PMID: 21289976
PMC: 3025587.
DOI: 10.2147/IJN.S15278.
Amyloid precursor protein and tau transgenic models of Alzheimer's disease: insights from the past and directions for the future.
Sahara N, Lewis J
Future Neurol. 2010; 5(3):411-420.
PMID: 20730022
PMC: 2922751.
DOI: 10.2217/fnl.10.10.
Alzheimer's disease and the amyloid-beta peptide.
Murphy M, LeVine 3rd H
J Alzheimers Dis. 2010; 19(1):311-23.
PMID: 20061647
PMC: 2813509.
DOI: 10.3233/JAD-2010-1221.
Time-dependent insulin oligomer reaction pathway prior to fibril formation: cooling and seeding.
Sorci M, Grassucci R, Hahn I, Frank J, Belfort G
Proteins. 2009; 77(1):62-73.
PMID: 19408310
PMC: 2737737.
DOI: 10.1002/prot.22417.
Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice.
Thakker D, Weatherspoon M, Harrison J, Keene T, Lane D, Kaemmerer W
Proc Natl Acad Sci U S A. 2009; 106(11):4501-6.
PMID: 19246392
PMC: 2647980.
DOI: 10.1073/pnas.0813404106.
